Alpha 2.0
Login Register
» Authors » Chris Fuller

Chris Fuller

Explore the profile of Chris Fuller including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 234
Followers 0
Related Specialties
Infectious Diseases
Public Health
Geriatrics
Top 10 Co-Authors
Andrew Hayward
Laura Shallcross
Maria Krutikov
Andrew Copas
Paul Moss
Aidan Irwin-Singer
Gokhan Tut
Borscha Azmi
Susan Michie
David Bone
Published In
Lancet Healthy Longev
Am J Infect Control
Mar Pollut Bull
Lancet Infect Dis
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Understanding prenatal household exposures to per- and polyfluorylalkyl substances using paired Biological and dust measurements with sociodemographic and housing variables
Wallis D, Miller K, DeLuca N, Thomas K, Fuller C, McCord J, et al.
Environ Int . 2024 Dec; 194:109157. PMID: 39642652
Per- and poly-fluoroalkyl substances (PFAS) are chemicals of concern-they are ubiquitous, persistent, with known and suspected health impacts. Well studied, primary sources of exposure to PFAS are drinking water and...
2.
VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in England
Krutikov M, Bone D, Stirrup O, Bruton R, Azmi B, Fuller C, et al.
Wellcome Open Res . 2024 Oct; 8:553. PMID: 39364338
VIVALDI (ISRCTN14447421) is a government-funded longitudinal open observational cohort study of staff and residents in care homes for older people in England. The study aimed to describe epidemiology (including seroprevalence)...
3.
Built Environment and SARS-CoV-2 Transmission in Long-Term Care Facilities: Cross-Sectional Survey and Data Linkage
Krutikov M, Stirrup O, Fuller C, Adams N, Azmi B, Irwin-Singer A, et al.
J Am Med Dir Assoc . 2023 Dec; 25(2):304-313.e11. PMID: 38065220
Objectives: To describe the built environment in long-term care facilities (LTCF) and its association with introduction and transmission of SARS-CoV-2 infection. Design: Cross-sectional survey with linkage to routine surveillance data....
4.
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection
Tut G, Lancaster T, Butler M, Sylla P, Spalkova E, Bone D, et al.
Nat Aging . 2023 Apr; 2(6):536-547. PMID: 37118449
We studied humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a prospective 4-month period shortly after...
5.
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study
Krutikov M, Stirrup O, Nacer-Laidi H, Azmi B, Fuller C, Tut G, et al.
Lancet Healthy Longev . 2022 May; 3(5):e347-e355. PMID: 35531432
Background: The SARS-CoV-2 omicron variant (B.1.1.529) is highly transmissible, but disease severity appears to be reduced compared with previous variants such as alpha and delta. We investigated the risk of...
6.
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI)
Stirrup O, Krutikov M, Tut G, Palmer T, Bone D, Bruton R, et al.
J Infect Dis . 2022 Apr; 226(11):1877-1881. PMID: 35429382
General population studies have shown strong humoral response following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination with subsequent waning of anti-spike antibody levels. Vaccine-induced immune responses are often attenuated...
7.
Storytelling as a Research Tool Used to Explore Insights and as an Intervention in Public Health: A Systematic Narrative Review
McCall B, Shallcross L, Wilson M, Fuller C, Hayward A
Int J Public Health . 2021 Nov; 66:1604262. PMID: 34795554
Studies of storytelling (ST) used as a research tool to extract information and/or as an intervention to effect change in the public knowledge, attitudes, and behavior/practice (KAB/P) were sought and...
8.
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study
Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Kaur N, et al.
Lancet Healthy Longev . 2021 Aug; 2(9):e544-e553. PMID: 34430954
Background: Residents of long-term care facilities (LTCFs) have been prioritised for COVID-19 vaccination because of the high COVID-19 mortality in this population. Several countries have implemented an extended interval of...
9.
Feasibility study of hospital antimicrobial stewardship analytics using electronic health records
Dutey-Magni P, Gill M, McNulty D, Sohal G, Hayward A, Shallcross L, et al.
JAC Antimicrob Resist . 2021 Jul; 3(1):dlab018. PMID: 34223095
Background: Hospital antimicrobial stewardship (AMS) programmes are multidisciplinary initiatives to optimize antimicrobial use. Most hospitals depend on time-consuming manual audits to monitor clinicians' prescribing. But much of the information needed...
10.
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
Krutikov M, Palmer T, Tut G, Fuller C, Shrotri M, Williams H, et al.
Lancet Healthy Longev . 2021 Jun; 2(6):e362-e370. PMID: 34104901
Background: SARS-CoV-2 infection represents a major challenge for long-term care facilities (LTCFs) and many residents and staff are seropositive following persistent outbreaks. We aimed to investigate the association between the...